University of Surrey

Test tubes in the lab Research in the ATI Dance Research

The price of medicines in Jordan: The cost of trade-based intellectual property

Abbott, RB, Bader, R, Bajjali, L, Elsamen, TA, Obeidat, T, Sboul, H, Shwayat, M and Alabbadi, I (2012) The price of medicines in Jordan: The cost of trade-based intellectual property Journal of Generic Medicines, 9 (2). pp. 75-85.

Full text not available from this repository.

Abstract

Jordan dramatically strengthened the level of intellectual property protection it provides for pharmaceutical products in consequence of joining the World Trade Organization in 2000 and signing a Free Trade Agreement with the United States in 2001. This study assesses the impact of higher levels of intellectual property protection on access to medicines by quantifying the effects on the private retail pharmaceutical market of delayed market entry of generic products. Adjusted for increased sales volume and inflation, from 1999 to 2004 there was a 17% increase in total annual expenditure for medicines in Jordan. When assessing originator medicines that were marketed in both 1999 and 2004, and for which there were generic equivalents, the weighted average price of originator medicines increased while the weighted average price of equivalent generic medicines decreased. Delayed market entry of generics due to enhanced intellectual property protection is estimated to have cost Jordanian private consumers approximately 18 million U.S. dollars in 2004. Jordan should consider amending its current regulatory scheme on data protection and amending the Unfair Competition and Trade Secrets Law of 2000. Jordan should also consider increased spending on public health to offset the adverse impact on consumers of strengthening its intellectual property protection relevant to pharmaceutical products. © 2012 The Author(s).

Item Type: Article
Subjects : Law
Authors :
NameEmailORCID
Abbott, RBr.abbott@surrey.ac.ukUNSPECIFIED
Bader, RUNSPECIFIEDUNSPECIFIED
Bajjali, LUNSPECIFIEDUNSPECIFIED
Elsamen, TAUNSPECIFIEDUNSPECIFIED
Obeidat, TUNSPECIFIEDUNSPECIFIED
Sboul, HUNSPECIFIEDUNSPECIFIED
Shwayat, MUNSPECIFIEDUNSPECIFIED
Alabbadi, IUNSPECIFIEDUNSPECIFIED
Date : June 2012
Identification Number : https://doi.org/10.1177/1741134312447499
Copyright Disclaimer : © 2012 The Author(s).
Uncontrolled Keywords : Access to medicines, intellectual property, US-Jordan free trade agreement, generic drug, article, consumer, contract, developing country, drug cost, drug industry, drug marketing, food and drug administration, health care access, health care availability, international relations, investment, Jordan, patent, prediction, public health
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 16 May 2017 15:37
Last Modified : 18 May 2017 13:13
URI: http://epubs.surrey.ac.uk/id/eprint/820914

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800